Congress orders study on fentanyl testing for overdose patients
H.R. 2004 — Tyler’s Law · Filed by Ted Lieu (D-CA) · 65 cosponsors · Introduced Mar 10, 2025 · Reported out
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to study whether hospital emergency departments should routinely test overdose patients for fentanyl, examining testing frequency, costs, patient benefits and risks, and privacy implications. Within 18 months total, HHS must issue guidance recommending whether fentanyl testing should become standard practice and how hospitals can ensure clinicians know what substances their drug tests screen for.
Why we flagged it
The bill is a straightforward directive to HHS to conduct research and issue clinical guidance on a specific public health practice (fentanyl testing in overdose care). It creates no new law, no restrictions, and no private carve-outs—only a study-and-guidance mechanism.
What the text implies
- Guidance may influence hospital liability and malpractice exposure if fentanyl testing becomes standard of care; hospitals may face claims for failure to test once guidance recommends it.
- Fentanyl identification could improve treatment outcomes but may also increase stigma or law-enforcement involvement if test results are shared beyond clinical care.
The full analysis lists 3 implications of this text.
Who stands to gain
clinical laboratory companies (fentanyl test kit manufacturers); hospital systems (if testing becomes standard, driving volume)